feed,title,long_url,short_url
ğŸ”MarketWatch,Cypress Development started at buy with C$3.75 stock price target at Alliance Global,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=CYDVF&siteid=rss,https://on.mktw.net/3HW8st3
ğŸ”MarketWatch,Kymera Therapeutics started at neutral with $44 stock price target at J.P. Morgan,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=KYMR&siteid=rss,https://on.mktw.net/3CthmgF
ğŸ”MarketWatch,C4 Therapeutics started at overweight with $43 stock price target at J.P. Morgan,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=CCCC&siteid=rss,https://on.mktw.net/3MEFKQT
ğŸ”MarketWatch,Toll Brothers upgraded to neutral from underweight at J.P. Morgan,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=TOL&siteid=rss,https://on.mktw.net/3IxMez3
ğŸ”MarketWatch,Meritage Homes downgraded to neutral from overweight at J.P. Morgan,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=MTH&siteid=rss,https://on.mktw.net/328rDRA
